About this trial
Numerous plant-based foods contain bioactive compounds, in particular polyphenols, which have antioxidant, anti-inflammatory, and metabolic regulatory effects. These so-called food bioactives (FB) are converted in the human organism, in particular by the gut microbiota and microsomal (liver/intestinal) metabolism, into numerous metabolites, which often represent the actual biologically active molecules. As part of the European HORIZON-MSCA Doctoral Network "BioTransform," two such food models are being studied as examples: 1. Olive products (Olea europaea L.) - representative of the Mediterranean diet, rich in secoiridoids and phenylethanols (especially hydroxytyrosol and tyrosol). 2.
Bilberry /blueberry (Vaccinium myrtillus L.) - representative of the Central European diet, rich in anthocyanosides. Two parallel human intervention studies will be conducted, one in Graz (WP1, DC5) and one in Athens (WP1, DC3). These pilot studies will generate biological samples (blood, urine, stool) and investigate the extent to which taking these standardized dietary supplements influences glucose metabolism and markers of oxidative stress and low-grade inflammation.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
30-50 years old,
BMI> 25 kg/m2
prediabetic stage
hsCRP> 2mg/ L
Disqualifiers
No signed informed consent
Supplementation or probiotic usage in the past 8 weeks
Chronic gastrointestinal, inflammatory or metabolic diseases
Alcohol misuse
Trial design
Crossover
Treatments tested in this trial
supplementation, food
Dietary supplementThrough this pilot clinical study, the possible change of inflammatory and oxidative stress biomarkers in prediabetic, overweigh/ obese people will be observed. Blood, urine and stool samples will be collected, while weight mangment will also be controlled.
Treatment groups
Trial outcomes
Primary outcomes
Changes in inflammatory and oxidative stress markers
The changes in the inflammatory and oxidative stress markers will be assessed through blood samples and the biomarkers: hsCRP, IL-6, TNF-a, total antioxidant capacity, ratio glutathione/ oxidiced glutathion
Secondary outcomes
Lipid profile
Blood samples: TCHOL, HDL, LDL, TG
Inflammatory profile
Blood samples: ICAM-1, VCAM-1, CRP-C
Anthropometric profile
Body measurements: BMI and body weight changes
Metabolic profile
Urine and plasma samples: metabolite profile in urine and plasma
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: